Innate Pharma
Marseille
About Innate Pharma
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $339.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2025)
- Ticker: epa:IPH
- Website: innate-pharma.com
- Phone: +33 (0)4 30 30 30 30
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/innate-pharma-128054 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.